You have 9 free searches left this month | for more free features.

abemaciclib

Showing 26 - 50 of 137

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Abemaciclib
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Nov 1, 2022

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)

Recruiting
  • Adenocarcinoma of Endometrium
  • Basking Ridge, New Jersey
  • +6 more
Oct 12, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • Abemaciclib
  • Lutetium Lu 177-PSMA-617
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Abemaciclib
  • +2 more
  • Mineola, New York
  • +14 more
Aug 23, 2023

Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)

Recruiting
  • Advanced Dedifferentiated Liposarcoma
  • Abemaciclib
  • Placebo
  • Jacksonville, Florida
  • +6 more
Jul 27, 2022

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Abemaciclib
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

HNSCC Trial in Tucson (Abemaciclib)

Recruiting
  • HNSCC
  • Abemaciclib
  • Tucson, Arizona
    University of Arizona
Mar 3, 2022

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Abemaciclib
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 7, 2022

Breast Cancer Trial in Philadelphia (Abemaciclib, Hydroxychloroquine)

Recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 13, 2021

Breast Cancer Trial (ARV-471, Abemaciclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 1, 2023

Abemaciclib in Combination With Endocrine Therapy as First Line

Recruiting
  • Breast Cancer/ Metastatic Breast Cancer
  • Abemaciclib
  • Munich, Germany
    Klinikum rechts der Isar der TU München, Klinik und Poliklinik f
Apr 26, 2022

Cancer Metastatic Trial in Pierre Benite, Rennes (Paclitaxel injection, Capecitabine tablets, Letrozole 2.5mg)

Recruiting
  • Cancer Metastatic
  • Paclitaxel injection
  • +5 more
  • Pierre Benite, France
  • +1 more
May 11, 2022

Breast Cancer Trial in Aurora, Durham, Spokane Valley (Abemaciclib, Elacestrant)

Recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +2 more
May 10, 2022

Esophageal Adenocarcinoma, Esophagus SCC, Cholangiocarcinoma Trial in Belgium, France (Abemaciclib)

Active, not recruiting
  • Esophageal Adenocarcinoma
  • +4 more
  • Abemaciclib
  • Antwerpen, Belgium
  • +10 more
May 27, 2022

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

Biliary Tract Carcinoma Trial in Hershey (Abemaciclib)

Recruiting
  • Biliary Tract Carcinoma
  • Abemaciclib
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Feb 3, 2022

Glioblastoma Trial in Boston (Pembrolizumab, Abemaciclib)

Withdrawn
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
Dec 13, 2021

Bladder Cancer Trial in United States (Abemaciclib)

Recruiting
  • Bladder Cancer
  • Abemaciclib
  • Tampa, Florida
  • +3 more
Jul 27, 2022

Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

Recruiting
  • Chondrosarcoma
  • +2 more
  • Abemaciclib
  • Jacksonville, Florida
  • +3 more
Apr 4, 2022

Brain Tumor Trial in United States (abemaciclib)

Active, not recruiting
  • Brain Tumor
  • abemaciclib
  • Hartford, Connecticut
  • +7 more
Mar 30, 2022

Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
Jul 26, 2022

Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Abemaciclib
  • Bordeaux, France
  • +2 more
Jul 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Abemaciclib
  • +2 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022